---
title: "DaVita Inc. (DVA.US) — Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DVA.US/overview.md"
symbol: "DVA.US"
name: "DaVita Inc."
parent: "https://longbridge.com/en/quote/DVA.US.md"
datetime: "2026-04-05T09:38:16.394Z"
locales:
  - [en](https://longbridge.com/en/quote/DVA.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DVA.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DVA.US/overview.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DVA.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DVA.US/overview.md)


# DaVita Inc. (DVA.US) — Company Overview

## Basic Information

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Address | 2000 16th Street, Denver, Colorado, United States |
| Website | [www.davita.com](https://www.davita.com) |

## Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

## Key Executives

| Name | Title |
|------|-------|
| Javier J. Rodriguez | CEO & Executive Director |
| Pamela M. Arway | Independent Chair |
| Joel Ackerman | CFO & Treasurer |
| David P. Maughan | Chief Operating Officer of Kidney Care |
| Kathleen Alyce Waters | Chief Legal & Public Affairs Officer |
| James O. Hearty | Chief Compliance Officer |
| Barbara J. Desoer | Independent Director |
| Phyllis R. Yale | Independent Director |
| Gregory J. Moore | Independent Director |

## Major Shareholders

| Name | Ratio | Report Date |
|------|-------|-------------|
| Berkshire Hathaway Inc. | 45.08% | 2026-01-29 |
| The Vanguard Group, Inc. | 6.22% | 2025-12-31 |
| BlackRock, Inc. | 4.38% | 2025-12-31 |
| Invesco Capital Management LLC | 2.27% | 2025-12-31 |
| State Street Global Advisors, Inc. | 2.15% | 2025-12-31 |
| Arrowstreet Capital, Limited Partnership | 1.78% | 2025-12-31 |
| Millennium Management LLC | 1.76% | 2025-12-31 |
| Gates Capital Management, Inc. | 1.76% | 2025-12-31 |
| Dimensional Fund Advisors LP | 1.63% | 2025-12-31 |
| Geode Capital Management, LLC | 1.47% | 2025-12-31 |

## Business Breakdown

| Segment | Revenue | Ratio |
|---------|---------|-------|
| U.S. Dialysis Patient Services and Other | 11793000000 | 85.99% |
| Other - Ancillary Services - International | 1346000000 | 9.81% |
| Other - Ancillary Services - U.S. Integrated Kidney Care (IKC) | 542000000 | 3.95% |
| Other-Ancillary Services - U.S. Other Ancillary | 34000000 | 0.25% |
| Elimination of intersegment revenues | -72000000 | % |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "DaVita Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "U.S. Dialysis Patient Services and Other",
        "ratio": 85.99
      },
      {
        "segment": "Other - Ancillary Services - International",
        "ratio": 9.81
      },
      {
        "segment": "Other - Ancillary Services - U.S. Integrated Kidney Care (IKC)",
        "ratio": 3.95
      },
      {
        "segment": "Other-Ancillary Services - U.S. Other Ancillary",
        "ratio": 0.25
      },
      {
        "segment": "Elimination of intersegment revenues",
        "ratio": null
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**